Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-29 @ 12:14 PM
Study NCT ID:
NCT00775957
Status:
TERMINATED
Last Update Posted:
2010-09-28
First Post:
2008-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008228', 'term': 'Lymphoma, Non-Hodgkin'}], 'ancestors': [{'id': 'D008223', 'term': 'Lymphoma'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D008232', 'term': 'Lymphoproliferative Disorders'}, {'id': 'D008206', 'term': 'Lymphatic Diseases'}, {'id': 'D006425', 'term': 'Hemic and Lymphatic Diseases'}, {'id': 'D007160', 'term': 'Immunoproliferative Disorders'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 35}}, 'statusModule': {'whyStopped': 'Terminated by institutional review board', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2008-10'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2010-09', 'lastUpdateSubmitDate': '2010-09-27', 'studyFirstSubmitDate': '2008-10-17', 'studyFirstSubmitQcDate': '2008-10-17', 'lastUpdatePostDateStruct': {'date': '2010-09-28', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-10-20', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Staging and ReStaging scans', 'timeFrame': 'after hematopoetic recovery'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'conditions': ["Non-Hodgkin's Lymphoma"]}, 'descriptionModule': {'briefSummary': 'A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin\'s Lymphoma in comparison wit the "gold standard" FDG-PET.', 'detailedDescription': 'The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'Subjects diagnosed with lymphoma and are about to start treatment with chemotherapy', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* 18 years or older\n* Women must not be pregnant or breast feeding\n* Histologic diagnosis of non-Hodgkin's lymphoma (any stage)\n* Must undergo treatment with chemotherapy and/or radiotherapy\n\nExclusion Criteria:\n\n* May not have received previous therapy with radiopharmaceuticals\n* May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies"}, 'identificationModule': {'nctId': 'NCT00775957', 'briefTitle': "Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma", 'organization': {'class': 'OTHER', 'fullName': 'University of Oklahoma'}, 'officialTitle': "Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma", 'orgStudyIdInfo': {'id': 'FLT-NHL'}}, 'armsInterventionsModule': {'armGroups': [{'label': '1', 'description': 'FLT-PET Scan', 'interventionNames': ['Procedure: FLT-PET scan']}, {'label': '2', 'description': 'FDG-PET Scan', 'interventionNames': ['Procedure: FDG-PET scan']}], 'interventions': [{'name': 'FLT-PET scan', 'type': 'PROCEDURE', 'description': 'imaging scan', 'armGroupLabels': ['1']}, {'name': 'FDG-PET scan', 'type': 'PROCEDURE', 'description': 'imaging scan', 'armGroupLabels': ['2']}]}, 'contactsLocationsModule': {'locations': [{'zip': '73104', 'city': 'Oklahoma City', 'state': 'Oklahoma', 'country': 'United States', 'facility': 'University of Oklahoma Health Sciences Center', 'geoPoint': {'lat': 35.46756, 'lon': -97.51643}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of Oklahoma', 'class': 'OTHER'}, 'collaborators': [{'name': 'Midwest Medical Isotopes', 'class': 'UNKNOWN'}], 'responsibleParty': {'oldNameTitle': 'Jennifer Holter, MD', 'oldOrganization': 'University of Oklahoma Health Sciences Center- Dept. of Medicine'}}}}